Open Access Open Access  Restricted Access Subscription or Fee Access

CRP in Different Diseases

Priyanka Verma


CRP also known as C reactive protein which is produced by liver hepatocytes. CRP test is done to check inflammation level during infection. CRP levels help to determine heart disease, high blood pressure and other diseases. It is found elevated in diseases like blood pressure, in females having birth control pills, bacterial as well as metabolic inflammation. CRP levels are also found increased with age, pregnancy, mild and viral infections as well as in cases of burns, obesity, obstructive sleep apnea, rheumatoid arthritis, gum diseases, Inflammatory bowel disease (IBD), cancer, pneumonia, vision loss. Minor increase was also seen in cases of scleroderma, polymyositis, and dermatomyositis. So, it can be said that CRP is one of the important indicator for the diagnosis of certain diseases.


CRP, Heart diseases, Cancer, Rheumatoid arthritis, Inflammation

Full Text:



Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep. 2002; 4 (3): 250–5.

Fabrizio Montecucco and François Mach. New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin Interv Aging. 2008 Jun; 3 (2): 341–349.

Nicole Stancel, Chih-Chieh Chen, Liang-Yin Ke, Chih-Sheng Chu, Jonathan Lu, Tatsuya Sawamura, Chu-Huang Chen. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. Clin Chem. 2016 Feb; 62 (2): 320-7.

Sridevi Devaraj, Siegel, and Ishwarlal Jialal. Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?. Curr Atheroscler Rep. 2011; 13 (1): 31–42.

Alijan Ahmadi-Ahangar, Predictive ability of C-reactive protein for stroke. Caspian J Intern Med. 2016 Summer; 7 (3): 151–152.

Dhayana Dallmeier, Wolfgang Koenig Strategies for vascular disease prevention: the role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA₂) and lipoprotein(a) (Lp(a)). Best Pract Res Clin Endocrinol Metab. 2014 Jun; 28 (3): 281–94.

Virginie Dauphinot, Frédéric Roche, Michel P Kossovsky, Anne-Marie Schott, Vincent Pichot, Jean-Michel Gaspoz, Philippe Gosse, Jean-Claude Barthelemy. C-reactive protein implications in new-onset hypertension in a healthy population initially aged 65 years: the Proof study. J Hypertens. 2009 Apr; 27 (4): 736–43.

Sabina Cauci, Maria Pia Francescato, Francesco Curcio. Combined Oral Contraceptives Increase High-Sensitivity C-Reactive Protein but not Haptoglobin in Female Athletes.Sports Med. 2017 Jan; 47 (1): 175–185.

Camille Escadafal, Sandra Incardona, B Leticia Fernandez-Carballo, and Sabine Dittrich. The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings. BMJ Glob Health. 2020; 5 (5): e002396.

AleksandraWyczalkowska-Tomasik, Bozena Czarkowska-Paczek, Magdalena Zielenkiewicz, and Leszek Paczek. Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges. Arch Immunol Ther Exp (Warsz). 2016; 64: 249–254.

Bayar M. Najat Nakishbandy and Sabat A. M. Barawi. Level of C-reactive protein as an indicator for prognosis of premature uterine contractions. J Prenat Med. 2014 Jan-Mar; 8(1-2): 25–30.

Jae-Sik Jeon, Insoo Rheem, and Jae Kyung Kim. C-Reactive Protein and Reactive protein and Respiratory Viral Infection. Korean J Clin Lab Sci 2017; 49:15-21.

David Braig, Benedict Kaiser, Jan R. Thiele, Holger Bannasch, Karlheinz Peter, G. Björn Stark, Hans-Georg Koch, Steffen U. Eisenhardt. A conformational change of C-reactive protein in burn wounds unmasks its proinflammatory properties International Immunology, Volume 26, Issue 8, August 2014, Pages 467–478.

Ritsuko Nishide, Michiko Ando, Hidemitsu Funabashi, Yoshiko Yoda, Masataka Nakano, and Masayuki Shima. Association of serum hs-CRP and lipids with obesity in school children in a 12-month follow-up study in Japan. Environ Health Prev Med. 2015 Mar; 20 (2): 116–122.

Rafaella CP Luna, Christiane CC do Nascimento, Luiza S R Asciutti, Sylvia do CC Franceschini, Rosália Gouveia Filizola, Alcides da S Diniz, Ronei M de Moraes, Maria A A Rivera, Maria da CR Gonçalves, Maria JC Costa. Relation between glucose levels, high-sensitivity C-reactive protein (hs-CRP), body mass index (BMI) and serum and dietary retinol in elderly in population-based study. Arch Gerontol Geriatr. May-Jun 2012; 54 (3): 462–8.

PF Todendi, LG Possuelo, EI Klinger, CP Reuter, MS Burgos, DJ Moura, M Fiegenbaum, Andréia Rosane de Moura Valim. Low-grade inflammation markers in children and adolescents: Influence of anthropometric characteristics and CRP and IL6polymorphisms. Clinical Trial Cytokine. 2016 Dec; 88: 177–183.

Barbara H. Lourenço, Marly A. Cardoso, C-Reactive Protein Concentration Predicts Change in Body Mass Index during Childhood. PLoS One. 2014; 9 (3): e90357.

H Karamanli, D Kizilirmak, R Akgedik, M Bilgi..Serum levels of magnesium and their relationship with CRP in patients with OSA. Sleep Breath. 2017 May; 21 (2): 549–556.

Jacqueline M. Latina, N. A. Mark Estes, III, and Ann C. Garlitski. The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay. Pulm Med. 2013; 2013: 621736.

Maria I. Danila, Andrew O. Westfall, Krishnan Raman, Lang Chen, Richard J. Reynolds, Laura B. Hughes, MSPH, Donna K. Arnett, Gerald McGwin, Alexander J. Szalai, Désirée M. van der Heijde, Doyt Conn, Leigh F. Callahan, Larry W. Moreland, and S. Louis Bridges, Jr. The Role of Genetic Variants in CRP in Radiographic Severity in African Americans with Early and Established Rheumatoid Arthritis. Genes Immun. 2015 Oct; 16 (7): 446–451.

Marshelle S Warren, Steven G Hughes, Walter Singleton, Mason Yamashita, and Mark C Genovese. Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis. Arthritis Res Ther. 2015; 17 (1): 80.

Birgit Vogt, Barbara Führnrohr, Rüdiger Müller, Ahmed Sheriff. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity. 2007 Jun; 40 (4): 295–8.

Maya H Buch, Yohei Seto, Sarah J Bingham, Victoria Bejarano, Domini Bryer, Jo White, Paul Emery. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept. Arthritis Rheum. 2005 Jan; 52 (1): 42–8.

Tushika Bansal, Anita Pandey, Deepa D, and Ashish K Asthana. C-Reactive Protein (CRP) and its Association with Periodontal Disease: A Brief Review. J Clin Diagn Res. 2014 Jul; 8 (7): 21–24.

Stacy B Menees, Corey Powell, Jacob Kurlander, Akash Goel, William D Chey. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol. 2015 Mar; 110 (3): 444–54.

M Henriksen, J Jahnsen, I Lygren, N Stray, J Sauar, M H Vatn, B Moum. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008 Nov; 57 (11): 1518–23.

Hyong Jin Cho, Mika Kivimaki,, Julienne E. Bower, and Michael R. Irwin. Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study.Psychol Med. 2013 Aug; 43 (8): 10.1017/S0033291712002437

Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R. Orre IJ. Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res. 2011 Sep; 71 (3):136-41.

L.L. Carpenter, C.E. Gawuga, A.R. Tyrka, and L.H. Price. C-reactive protein, early life stress, and wellbeing in healthy adults. Acta Psychiatr Scand. 2012 Dec; 126 (6): 402–410.

Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013 Sep 25; 150 (3): 736–44.

Michael Daly. The relationship of C-reactive protein to obesity-related depressive symptoms: a longitudinal study. Obesity (Silver Spring). 2013 Feb; 21 (2): 248–50.

Bo Mi Song, Ju-Mi Lee, Wungrak Choi, Yoosik Youm,Sang Hui Chu, Yeong-Ran Park, and Hyeon Chang Kim. Association between C reactive protein level and depressive symptoms in an elderly Korean population: Korean Social Life, Health and Aging Project. BMJ Open. 2015; 5 (2): e006429

Radmila Topić, Davor Miličić, Zoran Štimac, Mladen Lončar, Vedran Velagić, Darko Marčinko, and Miro Jakovljević. Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders. Croat Med J. 2013 Oct; 54 (5): 453–459.

Ph Courtet, I Jaussent, C Genty, A M Dupuy, S Guillaume, D Ducasse, E Olié. Increased CRP levels may be a trait marker of suicidal attempt.EurNeuropsychopharmacol. 2015 Oct; 25 (10): 1824–31.

Gwenolé Loas, Elodie Dalleau, Héloïse Lecointe, Valérie Yon. Relationships between anhedonia, alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-reactive protein and serum lipid levels among 122 in patients with mood or anxious disorders. Psychiatry Res. 2016 Dec 30; 246: 296–302.

Emina Colak, Nada Majkic-Singh, Lepsa Zoric, Aleksandra Radosavljevic, and Natalija Kosanovic-Jakovic. The role of CRP and inflammation in the pathogenesis of age-related macular degeneration. Biochem Med (Zagreb). 2012 Feb; 22 (1): 39–48.

B. Adar Kravitz, B.S, Maria M. Corrada, Sc.D., and Claudia H. Kawas, M.D. Elevated c-reactive protein levels are associated with prevalent dementia in the oldest-old. Alzheimers Dement. 2009 Jul; 5 (4): 318–323.

Wang G, Wu C, Zhang Q, et al. C‐reactive protein level may predict the risk of COVID‐19 aggravation. Open Forum Infect Dis. 2020; 7 (5).

Marnell L, Mold C, Du Clos TW. C‐reactive protein: ligands, receptors, and role in inflammation. Clin Immunol. 2005; 117 (2): 104–111.

Young B, Gleeson M, Cripps AW. C‐reactive protein: a critical review. Pathology. 1991; 23 (2):118–124.

Pepys MB, Hirschfield GM. C‐reactive protein: a critical update. J Clin Invest. 2003; 111 (12): 1805–1812.

Peter C. Hart, Ibraheem M. Rajab, May Alebraheem, and Lawrence A. Potempa. Reactive Protein and Cancer—Diagnostic and Therapeutic Insights Front Immunol. 2020; 11: 595835.

E. GarcíaVázquez, J.A. Martínez, J. Mensa, F. Sánchez, M.A. Marcos, A. de Roux, A. Torres. C-reactive protein levels in community-acquired pneumonia. European Respiratory Journal 2003 21: 702–705.

Shu-HanYang, aChristopherChang Zhe-XiongLian. Polymyositis and dermatomyositis–challenges in diagnosis and management. Journal of Translational Autoimmunity Volume 2, December 2019, 100018.

Alexander J. Szalai. C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures.Clin Dev Immunol. 2004 Sep-Dec; 11 (3-4): 221–226.

Jeffrey C Edberg, Jianming Wu, Carl D Langefeld, Elizabeth E Brown, Miranda C Marion, Gerald McGwin Jr, Michelle Petri, Rosalind Ramsey-Goldman, John D Reveille, Summer G Frank, Kenneth M Kaufman, John B Harley, Graciela S Alarcón, Robert P Kimberly. Hum Mol Genet. 2008 Apr 15; 17 (8): 1147–55.

Chi Chiu Mok, Daniel J. Birmingham, Ling Yin Ho, Lee A. Hebert. High-sensitivity C-reactive protein, disease activity and cardiovascular risk factors in systemic lupus erythematos. Arthritis care and research. Volume65, Issue3 March 2013, Pages 441–447.


  • There are currently no refbacks.

Copyright (c) 2022 Research & Reviews: A Journal of Bioinformatics